The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Agilon Health, Inc. (NYSE: AGL) (“Agilon”).

On January 5, 2024, Agilon announced revised guidance expectations for 2023 revenue and stated that such revisions were due to an increase in medical expenses. The company also announced that its CFO would step down in 2024. Following this news, Agilon’s stock price fell $3.45 per share, or 28.56%, to close at $8.63 per share on January 5, 2024.

If you are an Agilon investor and would like to learn more about our investigation, please CLICK HERE to fill out our online form or contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or E-mail at info@ktmc.com. You can also click on the following link or paste it in your browser: https://www.ktmc.com/agilon-health-inc-investigation?utm_source=PR&utm_medium=link&utm_campaign=aglktm=r

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240110186069/en/